In one paragraphArticle in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Barbara de Oliveira BaptistaLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, RJ, Brazil.
Isabela Ferreira SoaresLaboratório de Imunoparasitologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, RJ, Brazil.
Hugo Amorim Dos Santos de SouzaLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0002-2544-2898 Jenifer Peixoto de BarrosLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, RJ, Brazil.
Evelyn Kety Pratt RiccioLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0002-4782-2605 Rodrigo Medeiros MartoranoLaboratório de Doenças Infecciosas na Amazônia Ocidental, Universidade Federal do Acre-Campus Floresta (UFAC), Cruzeiro do Sul 69895-000, AC, Brazil.ORCID 0000-0002-7775-6901 Rodrigo Nunes Rodrigues-da-SilvaLaboratório de Hantaviroses e Rickettsioses, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0002-9772-849X Linda Eva AmoahImmunology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra P.O. Box LG 25, Ghana.
Susheel Kumar SinghCentre for Translational Medicine and Parasitology, Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.ORCID 0000-0002-1489-8742 Michael TheisenCentre for Translational Medicine and Parasitology, Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.
Josué da Costa Lima-JuniorLaboratório de Imunoparasitologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0002-5848-404X Paulo Renato Rivas TotinoLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, RJ, Brazil.
Cláudio Tadeu Daniel-RibeiroLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0001-9075-1470 Lilian Rose Pratt-RiccioLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0003-4002-5889 Funding
Coordenação de Aperfeicoamento de Pessoal de Nível Superior Finance Code 001Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E26/211.112/2019Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro Pronex E-26/010.001268/2016Fundação Oswaldo Cruz INOVA VPPCB-007-FIO-18-2-46National Council for Scientific and Technological Development Project 425.422/2016-0
6 · The paper itselfAbstract
BACKGROUND/
objectivesThe GMZ2.6c malaria vaccine candidate is a multi-stage
methodsThis study was carried out using peripheral blood mononuclear cells (PBMCs) from individuals with active
resultsThe individuals infected by
conclusionsIndividuals exhibit cellular immune responses to MSP-3 and Pfs48/45 that are recalled following GMZ2.6c stimulation.
Indexed as
cellular immune responseGMZ2.6cmalaria vaccinePlasmodium falciparumT cell epitope mapping
Identifiers
PMID42188795
PMCPMC13211559
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390